I was fully expecting FDA approval for Senhance. They had been doing cases in Europe for years. I said it would ultimately be a commercial failure. Sales numbers so far support my belief. Did you see Q3 revenue? Yeah it was bad. More competition coming. Medtronic up soon with a multi port offering. Single port ramping up soon by ISRG and of course the other company. Verb still an unknown Medrobotics working on a flexible general surgery robot too. Gonna get crowded in the next couple years.
Market Data 
Markets 
AI
